Dyadic Announces Collaboration with Jiangsu Hengrui Medicine for Biologic Drug Development BioTech September 17, 2020 Dyadic International, Inc. (“Dyadic” or the “Company”) (NASDAQ:DYAI), a global biotechnology company focused on further applying its proprietary C1 gene…
